Tendo today announced a new agreement with InfuCare Rx®, a national infusion services provider, to expand access to high-quality, cost-effective infusion therapy through the Tendo Marketplace.
InfuCare Rx, Inc., including its affiliates and subsidiaries, clarifies that it has no affiliation with, and is a separate and distinct entity and company from, InfuCare, Ltd., BioMatrix Infusion Pharmacy, and LUX Infusion.
As a friendly reminder, please remember to notify InfuCare Rx® of any upcoming changes to your healthcare benefits before they become effective. Failure to do so before 12/31/2025 or prior to any shipments or services scheduled in the 2026 New Year may result in you being responsible for the cost of the medication and/or a delay in service.
InfuCare Rx, one of the nation's largest independent providers of specialty infusion services, announced it has completed a recapitalization of the business through a strategic founder-led equity buyback. Guggenheim Investments served as the strategic capital partner on behalf of certain of its clients for this milestone transaction. This transaction underscores InfuCare Rx management’s long-term commitment to the firm’s vision and values.
We are thrilled to share that InfuCare Rx® has opened a brand-new, state-of-the-art infusion suite in the Parkside Professionals Plaza at 2902 59th Street West, Suite S, Bradenton, FL. This space was designed with one goal in mind: to provide our patients with the most comfortable, safe, and supportive infusion experience possible.
On October 9th, we’ll be celebrating the grand opening with a special open house from 3:00–6:00 pm. We are inviting local physicians, pharmaceutical partners, and healthcare professionals to tour the new facility and experience the InfuCare Rx difference firsthand.